Suchergebnisse - "Perrone, Francesco"

PubPharm (22)

1

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cascinu, S. | Berardi, R. | Bianco, R. | +22

2

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer : Joint Analysis of MILES-3 and MILES-4 Phase III Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Gridelli, C. | Morabito, A. | Cavanna, L. | +27

CommentIn: J Clin Oncol. 2018 Sep 1;36(25):2571-2574. - PMID 30028655

3

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer : The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Pignata, S. | Scambia, G. | Bologna, A. | +25

4

Rationale and design of MILES-3 and MILES-4 studies : two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

enthalten in: Clinical lung cancer | 2014

von Gridelli, C. | Rossi, A. | Di Maio, M. | +14

5

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2013

von Reaume, M. | Leighl, N. | Mittmann, N. | +11

6

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2 : the CAPPA-2 study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2013

von Morabito, A. | Gebbia, V. | Di Maio, M. | +20

7

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Di Maio, M. | Leighl, N. | Gallo, C. | +26

8

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer : the TORCH randomized trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Gridelli, C. | Ciardiello, F. | Gallo, C. | +25

CommentIn: J Clin Oncol. 2013 Jan 10;31(2):288-9. - PMID 23233717

9

Conventional chemotherapy of advanced pancreatic cancer

enthalten in: Current drug targets | 2012

von Giuliani, F. | Di Maio, M. | Colucci, G. | +1

10

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2 : the G-STEP trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Gridelli, C. | Gallo, C. | Morabito, A. | +75